Skip to main content

Table 1 Clinical characteristics of seizure patients and control subjects

From: Disruption of the blood–brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels

Variable

Patient

Control

P value

Number (n)

31

25

 

Current age (years)

42.5 (15.1)

38.7 (17.6)

P > 0.05

Age at onset of epilepsy (years)

23.3 (14.8)

  

Gender (M:F), n

20/16

13/12

P > 0.05

Red blood cells (1012/l)

4.3

4.5

P > 0.05

White blood cells (109/l)

5.9

6.2

P > 0.05

Focus of seizure

   

Temporal, n (%)

13 (41.9)

  

Extratemporal, n (%)

18 (58.1)

  

Type of seizure

   

Single GTC seizure, n (%)

11 (35.5)

  

Repetitive GTC seizure, n (%)

20 (64.5)

  

Epilepsy duration (years)

6.3 (1–18)

  

Frequency of seizures (month)

1.5 (1–5)

  

Number of seizures

3.3 (1–10)

  

Total duration of seizure (min)

8.3 (2–13)

  

Time to sampling (h)

6.2 (3–15)

  

Anti-epileptic drugs used

21 (67.7)

  

No treatment

10 (32.3)

  
  1. Mann–Whitney U-test for continuous variables; cross tabulations and chi-square-test for categorical variables.